Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,937 DKK | +0.31% | +0.55% | -10.12% |
May. 21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
May. 21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
ETFs positioned on Genmab A/S
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.64% | 200 M€ | +16.70% | ||
1.28% | 48 M€ | +9.22% | ||
1.01% | 85 M€ | -0.54% | ||
0.75% | 17 M€ | +6.09% | - | |
0.56% | 727 M€ | +7.40% | ||
0.49% | 88 M€ | +10.37% | - | |
0.45% | 25 M€ | +3.23% | - | |
0.33% | 6 M€ | -.--% | - | |
0.33% | 4 M€ | -.--% | - | |
0.32% | 36 M€ | +2.36% | - | |
0.31% | 6 M€ | -.--% | ||
0.29% | 2 M€ | +9.19% | - | |
0.29% | 2 M€ | -.--% | - | |
0.24% | 29 M€ | +8.37% | - | |
0.20% | 7 M€ | +5.36% | - | |
0.19% | 20 M€ | +0.77% | - | |
0.14% | 3,859 M€ | +18.82% | - | |
0.14% | 469 M€ | -2.05% | ||
0.14% | 10 M€ | -3.35% | - | |
0.09% | 276 M€ | +11.40% | - | |
0.08% | 264 M€ | -.--% | - | |
0.08% | 187 M€ | +9.30% | - | |
0.08% | 477 M€ | +11.68% | ||
0.07% | 7 M€ | +0.11% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 283 M€ | +19.73% | ||
0.04% | 206 M€ | -.--% | ||
0.04% | 1,166 M€ | +0.26% | - | |
0.04% | 607 M€ | +0.05% | - | |
0.04% | 23 M€ | -.--% | - | |
0.04% | 786 M€ | -.--% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 18.16B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- GMAB Stock
- Funds and ETFs Genmab A/S